Free Trial

Banco Bilbao Vizcaya Argentaria S.A. Sells 4,112 Shares of The Cigna Group (NYSE:CI)

The Cigna Group logo with Medical background

Banco Bilbao Vizcaya Argentaria S.A. trimmed its position in The Cigna Group (NYSE:CI - Free Report) by 23.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 13,602 shares of the health services provider's stock after selling 4,112 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in The Cigna Group were worth $3,747,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Garden State Investment Advisory Services LLC bought a new stake in The Cigna Group in the third quarter worth $444,000. Advisory Resource Group increased its holdings in shares of The Cigna Group by 2.0% in the 3rd quarter. Advisory Resource Group now owns 13,163 shares of the health services provider's stock worth $4,560,000 after buying an additional 263 shares during the last quarter. Virtu Financial LLC raised its position in shares of The Cigna Group by 39.6% during the 3rd quarter. Virtu Financial LLC now owns 17,173 shares of the health services provider's stock valued at $5,949,000 after buying an additional 4,870 shares in the last quarter. Te Ahumairangi Investment Management Ltd lifted its holdings in shares of The Cigna Group by 7.9% in the 3rd quarter. Te Ahumairangi Investment Management Ltd now owns 20,330 shares of the health services provider's stock valued at $7,003,000 after acquiring an additional 1,490 shares during the last quarter. Finally, Pine Valley Investments Ltd Liability Co boosted its holdings in shares of The Cigna Group by 28.3% in the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 15,713 shares of the health services provider's stock worth $5,444,000 after purchasing an additional 3,466 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, insider Noelle K. Eder sold 9,944 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $320.00, for a total value of $3,182,080.00. Following the completion of the transaction, the insider now directly owns 13,406 shares in the company, valued at $4,289,920. The trade was a 42.59 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Elder Granger sold 2,376 shares of the firm's stock in a transaction dated Friday, March 14th. The shares were sold at an average price of $310.35, for a total value of $737,391.60. Following the sale, the director now owns 5,471 shares in the company, valued at $1,697,924.85. This trade represents a 30.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 43,751 shares of company stock valued at $13,603,991 over the last quarter. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts recently weighed in on CI shares. Barclays decreased their price target on The Cigna Group from $420.00 to $339.00 and set an "overweight" rating on the stock in a report on Friday, January 31st. Truist Financial raised their target price on shares of The Cigna Group from $375.00 to $385.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Wells Fargo & Company cut their price target on shares of The Cigna Group from $370.00 to $341.00 and set an "equal weight" rating on the stock in a report on Tuesday, February 4th. Morgan Stanley decreased their price objective on shares of The Cigna Group from $403.00 to $379.00 and set an "overweight" rating for the company in a research note on Friday, January 31st. Finally, Raymond James reaffirmed a "strong-buy" rating and set a $360.00 target price (down previously from $415.00) on shares of The Cigna Group in a research note on Friday, January 31st. Two investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and three have given a strong buy rating to the stock. Based on data from MarketBeat.com, The Cigna Group has a consensus rating of "Buy" and an average price target of $373.56.

Check Out Our Latest Analysis on The Cigna Group

The Cigna Group Stock Performance

Shares of The Cigna Group stock opened at $335.60 on Friday. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The company has a market capitalization of $91.85 billion, a PE ratio of 27.42, a P/E/G ratio of 0.98 and a beta of 0.51. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The company has a 50-day simple moving average of $319.82 and a two-hundred day simple moving average of $310.69.

The Cigna Group (NYSE:CI - Get Free Report) last posted its earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the previous year, the firm posted $6.79 EPS. Research analysts expect that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.80%. The ex-dividend date is Tuesday, June 3rd. The Cigna Group's dividend payout ratio is presently 49.35%.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI - Free Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in The Cigna Group Right Now?

Before you consider The Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.

While The Cigna Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Make Your Money Work Harder: The Power of Dividend Investing
7 Cybersecurity Stocks Outperforming the Market Right Now
Markets in Rally Mode: Will Earnings Keep It Going?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines